| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.35 | 0.02 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.28 | 0.07 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.26 | 0.2 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.25 | 0.09 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.23 | 0.09 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.2 | 0.1 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.18 | 0.2 |